{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:30:56Z","timestamp":1785184256326,"version":"3.55.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ 02648\/18"],"award-info":[{"award-number":["APQ 02648\/18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ 00265\/18"],"award-info":[{"award-number":["APQ 00265\/18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007378","name":"Universidade Federal de Juiz de Fora","doi-asserted-by":"publisher","award":["UFJF\/Brazil"],"award-info":[{"award-number":["UFJF\/Brazil"]}],"id":[{"id":"10.13039\/501100007378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Current therapeutic alternatives for the treatment of cryptococcosis are scarce, highly toxic, expensive, and difficult to access. Therefore, the aim of this study was to evaluate the anticryptococcal potential of a collection of 27 drugs in vitro against several strains of Cryptococcus neoformans and Cryptococcus gattii. We investigated several parameters to evaluate the antifungal activity of the drugs: determination of minimum inhibitory concentration (MIC), combinatorial effects with fluconazole, kinetics of growth inhibition, post-antifungal effect (PAFE), and morphometric analyses at subinhibitory concentrations. Antiparasitics albendazole, fenbendazole, flubendazole, mebendazole, and antidepressants duloxetine and paroxetine showed antifungal activity with an MIC of 100\u00a0\u00b5mol l\u22121 or less for most strains tested. The results of the zero-interaction power model indicated additive effects for combination of fluconazole with drugs finasteride, hydroxyzine, and paroxetine. The combined treatments significantly improved the ability of fluconazole to kill C. neoformans ATCC H99. Same phenomenon occurred in the in vitro PAFE, as the combinations suppressed fungal growth more effectively than fluconazole alone. A significant reduction in capsule size was observed. Screening of the drug collection showed interesting results, with benzimidazoles antiparasitics and serotonin and norepinephrine reuptake inhibitors in foreground. Finasteride, hydroxyzine, and paroxetine significantly improved activity of fluconazole in vitro.<\/jats:p>","DOI":"10.1093\/lambio\/ovaf045","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:27:09Z","timestamp":1744190829000},"source":"Crossref","is-referenced-by-count":1,"title":["Screening of drugs with potential antifungal activity for repurposing in the treatment of cryptococcosis"],"prefix":"10.1093","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7397-0858","authenticated-orcid":false,"given":"Emanuel Almeida Moreira","family":"de Oliveira","sequence":"first","affiliation":[{"name":"Multicentric Program in Biochemistry and Molecular Biology, Universidade Federal de Juiz de Fora , 35032-620, Governador Valadares ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6842-1934","authenticated-orcid":false,"given":"Gabriella Freitas","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Multicentric Program in Biochemistry and Molecular Biology, Universidade Federal de Juiz de Fora , 35032-620, Governador Valadares ,","place":["Brazil"]},{"name":"Department of Pharmacy, Universidade Federal de Juiz de Fora , 35032-620, Governador Valadares ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-6280","authenticated-orcid":false,"given":"Karen Luise","family":"Lang","sequence":"additional","affiliation":[{"name":"Multicentric Program in Biochemistry and Molecular Biology, Universidade Federal de Juiz de Fora , 35032-620, Governador Valadares ,","place":["Brazil"]},{"name":"Department of Pharmacy, Universidade Federal de Juiz de Fora , 35032-620, Governador Valadares ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"2025040909262707500_bib1","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-14-2681","article-title":"Brain penetration and efficacy of different mebendazole polymorphs in a mouse brain tumor model","volume":"21","author":"Bai","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2025040909262707500_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0732-8893(02)00473-X","article-title":"Comparison of methods of interpretation of checkerboard synergy testing","volume":"44","author":"Bonapace","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025040909262707500_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1574-6968.1990.tb04174.x","article-title":"An automated quantitative assay for fungal growth inhibition","volume":"69","author":"Broekaert","year":"1990","journal-title":"FEMS Microbiol Lett"},{"key":"2025040909262707500_bib4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/21505594.2018.1431087","article-title":"The capsule of Cryptococcus neoformans","volume":"10","author":"Casadevall","year":"2019","journal-title":"Virulence"},{"key":"2025040909262707500_bib5","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1128\/AAC.03137-14","article-title":"In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation","volume":"58","author":"Chavez-Dozal","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040909262707500_bib6","volume-title":"Clinical and Laboratory Standards Institute. M27-A2\u2014Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","author":"CLSI","year":"2008"},{"key":"2025040909262707500_bib7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1128\/AAC.38.2.378","article-title":"In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles","volume":"38","author":"Cruz","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040909262707500_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fmed.2019.00129","article-title":"Immunomodulatory role of capsular polysaccharides constituents of Cryptococcus neoformans","volume":"6","author":"Decote-Ricardo","year":"2019","journal-title":"Front Med"},{"key":"2025040909262707500_bib9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/myc.12353","article-title":"In vitro postantifungal effect, adhesion traits and haemolysin production of Candida dubliniensis isolates following exposure to 5-fluorocytosine","volume":"58","author":"Ellepola","year":"2015","journal-title":"Mycoses"},{"key":"2025040909262707500_bib10","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/jac\/dkt114","article-title":"The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii","volume":"68","author":"Ferreira","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2025040909262707500_bib11","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1128\/AAC.00466-15","article-title":"Heteroresistance to itraconazole alters the morphology and increases the virulence of Cryptococcus gattii","volume":"59","author":"Ferreira","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040909262707500_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bcp.2019.03.001","article-title":"The FICI paradigm: correcting flaws in antimicrobial in vitro synergy screens at their inception","volume":"163","author":"G\u00f3mara","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"2025040909262707500_bib13","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/cancers11091284","article-title":"Mebendazole as a candidate for drug repurposing in oncology: an extensive review of current literature","volume":"11","author":"Guerini","year":"2019","journal-title":"Cancers"},{"key":"2025040909262707500_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02681219780001081","article-title":"Discrepancy between in vitro and in vivo antifungal activity of albendazole","volume":"35","author":"Hardin","year":"1997","journal-title":"Med Mycol"},{"key":"2025040909262707500_bib15","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0190-9622(98)70482-7","article-title":"Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison","volume":"38","author":"Hazen","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"2025040909262707500_bib16","doi-asserted-by":"crossref","first-page":"114239","DOI":"10.1016\/j.ejmech.2022.114239","article-title":"Drug repositioning: progress and challenges in drug discovery for various diseases","volume":"234","author":"Hua","year":"2022","journal-title":"Eur J Med Chem"},{"key":"2025040909262707500_bib17","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2025040909262707500_bib18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat Rev Micro"},{"key":"2025040909262707500_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fmicb.2017.00535","article-title":"The anti-helminthic compound mebendazole has multiple antifungal effects against Cryptococcus neoformans","volume":"8","author":"Joffe","year":"2017","journal-title":"Front Microbiol"},{"key":"2025040909262707500_bib20","doi-asserted-by":"crossref","first-page":"a019760","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis","volume":"4","author":"Kwon-Chung","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025040909262707500_bib21","first-page":"e04562","article-title":"Antifungal peptide SP1 damages polysaccharide capsule of Cryptococcus neoformans and enhances phagocytosis of macrophages","volume":"11","author":"Liu","year":"2023","journal-title":"Microbiol Spectr"},{"key":"2025040909262707500_bib22","volume-title":"Brock Biology of Microorganisms","author":"Madigan","year":"2011","edition":"11th ed"},{"key":"2025040909262707500_bib23","doi-asserted-by":"crossref","first-page":"e20211021","DOI":"10.1590\/0001-3765202220211021","article-title":"Synergistic combination of duloxetine hydrochloride and fluconazole reduces the cell growth and capsule size of Cryptococcus neoformans","volume":"94","author":"Menezes","year":"2022","journal-title":"An Acad Bras Ci\u00eanc"},{"key":"2025040909262707500_bib24","doi-asserted-by":"publisher","first-page":"e00647","DOI":"10.1128\/mbio.00647-00615","article-title":"Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids","volume":"6","author":"Mor","year":"2015","journal-title":"mBio"},{"key":"2025040909262707500_bib25","doi-asserted-by":"publisher","first-page":"e01909","DOI":"10.1128\/aac.01909-01917","article-title":"Repurposing and reformulation of the antiparasitic agent flubendazole for treatment of cryptococcal meningoencephalitis, a neglected fungal disease","volume":"62","author":"Nixon","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040909262707500_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2025040909262707500_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00044-021-02824-4","article-title":"Drug repositioning of benzimidazole anthelmintics in the treatment of cryptococcosis: a review","volume":"31","author":"Oliveira","year":"2022","journal-title":"Med Chem Res"},{"key":"2025040909262707500_bib28","doi-asserted-by":"publisher","first-page":"e00286","DOI":"10.1128\/aac.00286-00220","article-title":"Fenbendazole Controls in vitro growth, virulence potential, and animal infection in the Cryptococcus model","volume":"64","author":"Oliveira","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040909262707500_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12281-017-0296-3","article-title":"Time-kill curves studies with amphotericin B against Cryptococcus neoformans\/C. gattii species complex clinical isolates","volume":"11","author":"Oliveira","year":"2017","journal-title":"Curr Fung Infect Rep"},{"key":"2025040909262707500_bib30","doi-asserted-by":"publisher","first-page":"ftab001","DOI":"10.1093\/femspd\/ftab001","article-title":"In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans","volume":"79","author":"Pereira","year":"2021","journal-title":"Pathog Dis"},{"key":"2025040909262707500_bib31","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s12223-024-01164-1","article-title":"Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii","volume":"69","author":"Rehem","year":"2024","journal-title":"Folia Microbiol (Praha)"},{"key":"2025040909262707500_bib32","doi-asserted-by":"publisher","first-page":"e01921","DOI":"10.1128\/aac.01921-01919","article-title":"Identification of off-patent drugs that show synergism with amphotericin B or that present antifungal action against Cryptococcus neoformans and Candida spp","volume":"64","author":"Rossi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025040909262707500_bib33","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.3389\/fmicb.2019.03150","article-title":"The antifungal peptide MCh-AMP1 derived from Matricaria chamomilla inhibits Candida albicans growth via inducing ROS generation and altering fungal cell membrane permeability","volume":"10","author":"Seyedjavadi","year":"2020","journal-title":"Front Microbiol"},{"key":"2025040909262707500_bib34","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"2016","journal-title":"Drug Discov Today"},{"key":"2025040909262707500_bib35","doi-asserted-by":"publisher","first-page":"e4761","DOI":"10.7717\/peerj.4761","article-title":"Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis","volume":"6","author":"Truong","year":"2018","journal-title":"PeerJ"},{"key":"2025040909262707500_bib36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41572-023-00472-z","article-title":"Cryptococcal meningitis","volume":"9","author":"Tugume","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"2025040909262707500_bib37","doi-asserted-by":"crossref","first-page":"114874","DOI":"10.1016\/j.addr.2023.114874","article-title":"New antifungal strategies: drug combination and co-delivery","volume":"198","author":"Zhu","year":"2023","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Letters in Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/78\/4\/ovaf045\/62722335\/ovaf045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/78\/4\/ovaf045\/62722335\/ovaf045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:27:13Z","timestamp":1744190833000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/lambio\/article\/doi\/10.1093\/lambio\/ovaf045\/8093557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/lambio\/ovaf045","relation":{},"ISSN":["1472-765X"],"issn-type":[{"value":"1472-765X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,25]]},"article-number":"ovaf045"}}